vs
Amentum Holdings, Inc.（AMTM）与TENET HEALTHCARE CORP（THC）财务数据对比。点击上方公司名可切换其他公司
TENET HEALTHCARE CORP的季度营收约是Amentum Holdings, Inc.的1.7倍（$5.5B vs $3.2B），TENET HEALTHCARE CORP净利率更高（11.7% vs 1.4%，领先10.3%），TENET HEALTHCARE CORP同比增速更快（9.0% vs -5.2%），TENET HEALTHCARE CORP自由现金流更多（$367.0M vs $-142.0M），过去两年Amentum Holdings, Inc.的营收复合增速更高（25.6% vs 1.5%）
本公司是总部位于美国达拉斯的跨国技术专业服务企业，面向全球企业、机构及政府部门客户提供工程、技术、建设服务以及科学与专项咨询服务，连续6年蝉联《工程新闻纪录》（ENR）全球顶尖设计企业500强榜首。
Tenet Healthcare Corporation是总部位于美国达拉斯的营利性跨国医疗服务企业，旗下拥有USPI等多个品牌、子公司、合资企业及合作主体，运营65家医院及超过450个医疗设施，还通过旗下Conifer Health Solutions为各类医疗系统及其他客户提供专业医疗支持服务
AMTM vs THC — 直观对比
营收规模更大
THC
是对方的1.7倍
$3.2B
营收增速更快
THC
高出14.2%
-5.2%
净利率更高
THC
高出10.3%
1.4%
自由现金流更多
THC
多$509.0M
$-142.0M
两年增速更快
AMTM
近两年复合增速
1.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.2B | $5.5B |
| 净利润 | $44.0M | $644.0M |
| 毛利率 | 10.1% | — |
| 营业利润率 | 4.3% | 15.4% |
| 净利率 | 1.4% | 11.7% |
| 营收同比 | -5.2% | 9.0% |
| 净利润同比 | 266.7% | 12.6% |
| 每股收益（稀释后） | $0.18 | $4.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMTMTHC
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.9B | $5.5B | ||
| Q3 25 | — | $5.3B | ||
| Q2 25 | $3.6B | $5.3B | ||
| Q1 25 | $3.5B | $5.2B | ||
| Q4 24 | $3.4B | $5.1B | ||
| Q3 24 | $2.2B | $5.1B | ||
| Q2 24 | $2.1B | $5.1B |
净利润AMTMTHC
| Q1 26 | $44.0M | — | ||
| Q4 25 | $40.0M | $644.0M | ||
| Q3 25 | — | $579.0M | ||
| Q2 25 | $10.0M | $522.0M | ||
| Q1 25 | $4.0M | $622.0M | ||
| Q4 24 | $12.0M | $572.0M | ||
| Q3 24 | $26.0M | $681.0M | ||
| Q2 24 | $-26.0M | $477.0M |
毛利率AMTMTHC
| Q1 26 | 10.1% | — | ||
| Q4 25 | 10.6% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 10.3% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 10.6% | — | ||
| Q3 24 | 9.0% | — | ||
| Q2 24 | 9.6% | — |
营业利润率AMTMTHC
| Q1 26 | 4.3% | — | ||
| Q4 25 | 3.4% | 15.4% | ||
| Q3 25 | — | 16.8% | ||
| Q2 25 | 2.9% | 15.6% | ||
| Q1 25 | 3.2% | 18.1% | ||
| Q4 24 | 3.9% | 16.2% | ||
| Q3 24 | 1.2% | 21.3% | ||
| Q2 24 | 4.2% | 14.9% |
净利率AMTMTHC
| Q1 26 | 1.4% | — | ||
| Q4 25 | 1.0% | 11.7% | ||
| Q3 25 | — | 10.9% | ||
| Q2 25 | 0.3% | 9.9% | ||
| Q1 25 | 0.1% | 11.9% | ||
| Q4 24 | 0.4% | 11.3% | ||
| Q3 24 | 1.2% | 13.3% | ||
| Q2 24 | -1.2% | 9.3% |
每股收益（稀释后）AMTMTHC
| Q1 26 | $0.18 | — | ||
| Q4 25 | $0.16 | $4.22 | ||
| Q3 25 | — | $3.86 | ||
| Q2 25 | $0.04 | $3.14 | ||
| Q1 25 | $0.02 | $4.27 | ||
| Q4 24 | $0.05 | $3.79 | ||
| Q3 24 | $0.31 | $4.89 | ||
| Q2 24 | $-0.29 | $2.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $247.0M | $2.9B |
| 总债务越低越好 | $3.9B | $13.1B |
| 股东权益账面价值 | $4.6B | $4.2B |
| 总资产 | $11.2B | $29.7B |
| 负债/权益比越低杠杆越低 | 0.86× | 3.10× |
8季度趋势，按日历期对齐
现金及短期投资AMTMTHC
| Q1 26 | $247.0M | — | ||
| Q4 25 | $437.0M | $2.9B | ||
| Q3 25 | — | $3.0B | ||
| Q2 25 | $738.0M | $2.6B | ||
| Q1 25 | $546.0M | $3.0B | ||
| Q4 24 | $522.0M | $3.0B | ||
| Q3 24 | $452.0M | $4.1B | ||
| Q2 24 | — | $2.9B |
总债务AMTMTHC
| Q1 26 | $3.9B | — | ||
| Q4 25 | $3.9B | $13.1B | ||
| Q3 25 | — | $13.1B | ||
| Q2 25 | $4.5B | $13.1B | ||
| Q1 25 | $4.7B | $13.1B | ||
| Q4 24 | $4.7B | $13.1B | ||
| Q3 24 | $4.7B | $12.8B | ||
| Q2 24 | — | $12.8B |
股东权益AMTMTHC
| Q1 26 | $4.6B | — | ||
| Q4 25 | $4.5B | $4.2B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | $4.5B | $3.7B | ||
| Q1 25 | $4.4B | $4.2B | ||
| Q4 24 | $4.5B | $4.2B | ||
| Q3 24 | $4.5B | $3.8B | ||
| Q2 24 | $303.0M | $3.5B |
总资产AMTMTHC
| Q1 26 | $11.2B | — | ||
| Q4 25 | $11.5B | $29.7B | ||
| Q3 25 | — | $29.4B | ||
| Q2 25 | $11.8B | $28.7B | ||
| Q1 25 | $12.0B | $29.2B | ||
| Q4 24 | $11.9B | $28.9B | ||
| Q3 24 | $12.0B | $29.4B | ||
| Q2 24 | — | $29.3B |
负债/权益比AMTMTHC
| Q1 26 | 0.86× | — | ||
| Q4 25 | 0.88× | 3.10× | ||
| Q3 25 | — | 3.26× | ||
| Q2 25 | 1.01× | 3.49× | ||
| Q1 25 | 1.06× | 3.13× | ||
| Q4 24 | 1.05× | 3.14× | ||
| Q3 24 | 1.05× | 3.33× | ||
| Q2 24 | — | 3.67× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-136.0M | $731.0M |
| 自由现金流经营现金流 - 资本支出 | $-142.0M | $367.0M |
| 自由现金流率自由现金流/营收 | -4.4% | 6.6% |
| 资本支出强度资本支出/营收 | 0.2% | 6.6% |
| 现金转化率经营现金流/净利润 | -3.09× | 1.14× |
| 过去12个月自由现金流最近4个季度 | $272.0M | $2.5B |
8季度趋势，按日历期对齐
经营现金流AMTMTHC
| Q1 26 | $-136.0M | — | ||
| Q4 25 | $270.0M | $731.0M | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | $106.0M | $936.0M | ||
| Q1 25 | $57.0M | $815.0M | ||
| Q4 24 | $110.0M | $-331.0M | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $747.0M |
自由现金流AMTMTHC
| Q1 26 | $-142.0M | — | ||
| Q4 25 | $261.0M | $367.0M | ||
| Q3 25 | — | $778.0M | ||
| Q2 25 | $100.0M | $743.0M | ||
| Q1 25 | $53.0M | $642.0M | ||
| Q4 24 | $102.0M | $-661.0M | ||
| Q3 24 | — | $829.0M | ||
| Q2 24 | — | $602.0M |
自由现金流率AMTMTHC
| Q1 26 | -4.4% | — | ||
| Q4 25 | 6.6% | 6.6% | ||
| Q3 25 | — | 14.7% | ||
| Q2 25 | 2.8% | 14.1% | ||
| Q1 25 | 1.5% | 12.3% | ||
| Q4 24 | 3.0% | -13.0% | ||
| Q3 24 | — | 16.2% | ||
| Q2 24 | — | 11.8% |
资本支出强度AMTMTHC
| Q1 26 | 0.2% | — | ||
| Q4 25 | 0.2% | 6.6% | ||
| Q3 25 | — | 5.3% | ||
| Q2 25 | 0.2% | 3.7% | ||
| Q1 25 | 0.1% | 3.3% | ||
| Q4 24 | 0.2% | 6.5% | ||
| Q3 24 | — | 4.2% | ||
| Q2 24 | — | 2.8% |
现金转化率AMTMTHC
| Q1 26 | -3.09× | — | ||
| Q4 25 | 6.75× | 1.14× | ||
| Q3 25 | — | 1.83× | ||
| Q2 25 | 10.60× | 1.79× | ||
| Q1 25 | 14.25× | 1.31× | ||
| Q4 24 | 9.17× | -0.58× | ||
| Q3 24 | — | 1.53× | ||
| Q2 24 | — | 1.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMTM
| Global Engineering Solutions Segment | $1.9B | 59% |
| Other U.S.Government Agencies | $400.0M | 12% |
| Fixed Price Contract | $380.0M | 12% |
| Commercial And International | $226.0M | 7% |
| Time And Materials Contract | $171.0M | 5% |
| Sales Channel Through Intermediary | $78.0M | 2% |
| Equity Method Investee | $50.0M | 2% |
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |
